PD-L1 cell surface expression was significantly upregulated (>20% PD-L1+ cells) by IFN-γ/TNF-α treatment in AML cells of 7 out of 10 newly diagnosed patients, whereas the expression of PD-L2 was only slightly induced. The gene discussed is IFNG; the disease is acute myeloid leukemia.